Renalytix is a pioneering healthcare company specializing in the development of artificial intelligence-enabled diagnostics for kidney disease. They generate revenue by creating and selling advanced diagnostic tools that help in the early detection and risk assessment of chronic kidney disease, which can lead to better patient outcomes and reduced healthcare costs. Founded in 2018, Renalytix has formed strategic partnerships with leading medical institutions and has received regulatory approvals for its flagship product, KidneyIntelX, which underscores its commitment to transforming kidney health management.